Acute myeloid leukaemia arising from a patient with untreated essential thrombocythaemia

被引：3

作者：

Bolaños-Meade, J

López-Arvizu, C

Cobos, E

机构：

[1] Texas Tech Univ, Dept Internal Med, Div Hematol & Oncol, Hlth Sci Ctr, Lubeck, Germany

[2] SW Canc Ctr, Lubeck, Germany

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2002年 / 68卷 / 06期

关键词：

acute myelogenous leukaemia; essential thrombocythaemia;

D O I：

10.1034/j.1600-0609.2002.02730.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute myeloid leukaemia (AML) is an uncommon complication of patients with essential thrombocythaemia (ET). We report a patient with ET which progressed into AML and who had only received a few days of therapy with hydroxyurea (HU) when diagnosed with ET. This is extremely rare, as in large series no patients who were left untreated for their ET developed this complication. This case supports the theory that AML transformation can be part of the natural history of ET in some cases.

引用

页码：397 / 399

页数：3

共 13 条

[1] Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment [J].

Andersson, PO ;

Ridell, B ;

Wadenvik, H ;

Kutti, J .

ANNALS OF HEMATOLOGY, 2000, 79 (01) :40-42

[2]

CERVANTES F, 1991, ACTA HAEMATOL-BASEL, V85, P124

[3] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[4]

CHISTOLINI A, 1990, HAEMATOLOGICA, V75, P537

[5] Treatment of essential thrombocythemia with special emphasis on leukemogenic risk [J].

Finazzi, G ;

Barbui, T .

ANNALS OF HEMATOLOGY, 1999, 78 (09) :389-392

[6]

GELLER SA, 1982, AM J CLIN PATHOL, V77, P353

[7]

Nand S, 1996, AM J HEMATOL, V52, P42, DOI 10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO

[8]

2-6

[9] Leukemia and myelodysplasia effect of multiple cytotoxic therapy in essential thrombocythemia [J].

Randi, ML ;

Fabris, F ;

Girolami, A .

LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) :379-385

[10]

RAZZAN M, 1999, ANN HEMATOL, V78, P539

← 1 2 →